THADA调控胰岛β细胞功能和存活参与2型糖尿病发生发展的作用及机制研究
批准号:
82100839
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
张玉青
依托单位:
学科分类:
胰岛生理调控与功能异常
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
张玉青
中文摘要
2型糖尿病的发病基础是遗传和环境因素引起的胰岛β细胞功能缺陷及容量不足。THADA是2型糖尿病的重要易感基因,与人群胰岛素分泌的反应性密切相关,且可参与调节果蝇产热。但THADA在血糖稳态维持及2型糖尿病发病中的作用未知。我们前期工作首次发现:THADA全身性敲除小鼠的葡萄糖耐量显著改善,体内外葡萄糖刺激的胰岛素分泌增多且β细胞凋亡减少,伴有胰岛内质网钙含量及CAMKⅡ磷酸化的增加。据此我们提出假设:THADA敲除可通过激活内质网钙-钙调蛋白-CAMKⅡ信号轴引起β细胞功能增强、凋亡减少及活力增加,从而改善小鼠血糖稳态并延缓2型糖尿病的发生。本研究拟利用该基因β细胞特异性敲除小鼠及转录激活的β细胞系,结合高脂高糖饮食诱导的2型糖尿病小鼠模型,系统阐明THADA对糖代谢和胰岛β细胞的调控作用及其分子机制,为揭示2型糖尿病的发病机制提供理论依据,并为研发具有β细胞保护作用的降糖药物提供新靶点。
英文摘要
Genetic and environmental factor-induced defective pancreatic β-cell function and insufficient β-cell mass underlies the pathogenesis of type 2 diabetes mellitus (T2DM). As a key susceptible gene for T2DM,THADA is closely associated with the insulin secretory response of subjects. It is also involved in regulating thermogenesis of Drosophila. However, the role of THADA in the maintenance of glucose homeostasis and the development of type 2 diabetes is unknown. Our preliminary work for the first time uncovered that whole-body THADA-knockout mice exhibited significantly improved glucose tolerance, enhanced glucose-stimulated insulin secretion in vivo and ex vivo, as well as decreased β-cell apoptosis. Meanwhile the endoplasmic reticulum (ER) calcium store and CAMKⅡ phosphorylation were increased in islets. In view of the above, we propose that THADA knockout could enhance β-cell function, inhibit β-cell apoptosis and increase β-cell viability by activating the ER calcium-calmodulin-CAMKⅡ signaling axis, leading to improved glucose homeostasis and prevention of T2DM onset in mice. In this study we’ll use the β-cell-specific knockout mice and transcriptionally activated β-cell line, combined with high-fat-high-sucrose diet-induced type 2 diabetes mouse model, to systematically elucidate the regulatory effects of THADA on glucose metabolism and pancreatic β-cell, as well as its molecular mechanism. This will establish the theoretical basis for revealing the pathogenesis of T2DM, also provide new targets for the development of glucose-lowering drugs with β-cell protective effects.
遗传和环境因素引起的胰岛β细胞功能缺陷及β细胞容量不足是2型糖尿病的发病基础。本项目聚焦2型糖尿病的重要易感基因THADA,首次揭示了其在血糖稳态中的关键调控作用及分子机制:发现THADA表达水平在2型糖尿病患者和小鼠的胰岛中显著上调;利用Thada基因全身性敲除小鼠、胰岛β细胞特异性敲除小鼠及Thada转录激活β细胞系,结合高脂高糖饮食诱导的2型糖尿病小鼠模型,系统阐明了THADA缺失通过增强β细胞功能和β细胞容量而对血糖稳态和2型糖尿病发挥改善作用;在分子机制上,THADA通过SERCA2和RyR2减少β细胞内质网Ca2+的储存量,并在内质网应激下结合并激活DR5、FADD和caspase-8组成的促凋亡复合体,从而加重内质网应激诱导的细胞凋亡。本项目为揭示2型糖尿病的发病机制提供了理论依据,并为研发具有β细胞保护作用的降糖药物提供了新靶点。
THADA调控LDL胆固醇摄取介导肝脏-卵巢代谢互作参与PCOS发病的作用及机制研究
-
批准号:82371644
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:张玉青
-
依托单位:
国内基金
海外基金